These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1662629)

  • 21. Disk diffusion sensitivity testing and antibacterial activity of azithromycin.
    Davila D; Tambić T; Djokić S; Kolacny-Babić L
    Arzneimittelforschung; 1992 Feb; 42(2):156-9. PubMed ID: 1319164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2.
    Ednie LM; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1998 Mar; 41(3):387-9. PubMed ID: 9578166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents.
    Credito KL; Lin G; Pankuch GA; Bajaksouzian S; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2001 Jan; 45(1):67-72. PubMed ID: 11120946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrum of activity of azithromycin.
    Williams JD
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):813-20. PubMed ID: 1662624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility testing of macrolide and lincosamide antibiotics according to DIN guidelines. Deutsches Institut für Normung.
    Schmalreck AF; Kottmann I; Reiser A; Ruffer U; Schlenk R; Vanca E; Wildfeuer A
    J Antimicrob Chemother; 1997 Aug; 40(2):179-87. PubMed ID: 9301982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dirithromycin disc susceptibility tests: interpretative criteria and quality control parameters.
    Barry AL; Pfaller MA; Fuchs PC
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():27-37. PubMed ID: 8478310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical microbiology of azithromycin.
    Neu HC
    Am J Med; 1991 Sep; 91(3A):12S-18S. PubMed ID: 1656736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of 50S ribosomal subunit assembly in Haemophilus influenzae cells by azithromycin and erythromycin.
    Champney WS; Miller M
    Curr Microbiol; 2002 Jun; 44(6):418-24. PubMed ID: 12000992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in vitro profile of selected 14-membered azalides.
    Jones AB; Herbert CM
    J Antibiot (Tokyo); 1992 Nov; 45(11):1785-91. PubMed ID: 1334956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Azithromycin: critical points].
    Philippon A; Cluzel R; Soussy CJ
    Pathol Biol (Paris); 1995 Jun; 43(6):488-97. PubMed ID: 8539070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of 6-O-methyl-azithromycin and its ketolide analogue via Beckmann rearrangement of 9(E)-6-O-methyl-erythromycin oxime.
    Denis A; Agouridas C
    Bioorg Med Chem Lett; 1998 Sep; 8(18):2427-32. PubMed ID: 9873555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
    Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
    J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disk diffusion and disk elution tests with A-56268 and erythromycin.
    Barry AL; Jones RN; Thornsberry C
    Eur J Clin Microbiol; 1987 Feb; 6(1):109-11. PubMed ID: 2952500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection.
    Vallée E; Azoulay-Dupuis E; Pocidalo JJ; Bergogne-Bérézin E
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1412-7. PubMed ID: 1324644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro antibacterial activity of clarithromycin, a new macrolide antibiotic, and regression curve].
    Soussy CJ; Le Van Thoi J; Cluzel M; Derlot E; Kitzis MD
    Pathol Biol (Paris); 1990 May; 38(5):401-6. PubMed ID: 2142274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae.
    Jorgensen JH; McElmeel ML
    J Antimicrob Chemother; 1997 May; 39 Suppl A():69-73. PubMed ID: 9511067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of carbon dioxide on the susceptibility of key respiratory tract pathogens to telithromycin and azithromycin.
    Bouchillon SK; Johnson JL; Hoban DJ; Stevens TM; Johnson BM
    J Antimicrob Chemother; 2005 Jul; 56(1):224-7. PubMed ID: 15890718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxyrase, a method which avoids CO2 in the incubation atmosphere for anaerobic susceptibility testing of antibiotics affected by CO2.
    Spangler SK; Appelbaum PC
    J Clin Microbiol; 1993 Feb; 31(2):460-2. PubMed ID: 8381817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH; Friedel HA; McTavish D
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azithromycin: an interim analysis.
    Ball AP
    J Int Med Res; 1991; 19(6):446-50. PubMed ID: 1663467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.